Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.9%
    Check dated 2025-07-04T04:09:42.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.7%
    Check dated 2025-06-19T19:58:13.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:20:10.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T06:05:59.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:24:37.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed study information regarding a clinical trial for glioblastoma and the addition of a new version revision. The collaborators' information has been retained, but the study's purpose and criteria have been deleted.
    Difference
    7%
    Check dated 2025-04-16T11:05:58.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.